Gefinat 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Natco Pharma Ltd
  4. Gefinat 250 mg Tablet

Gefinat 250 mg Tablet

Gefinat 250 mg Tablet contains gefitinib 250 mg, a targeted anticancer medicine that blocks epidermal growth factor receptor (EGFR) signaling. It is used for locally advanced or metastatic non-small cell lung cancer with activating EGFR mutations. The tablet is taken orally once daily as prescribed by a qualified healthcare professional.

BUY NOW

Category

Gefitinib inhibits EGFR tyrosine kinase activity, helping slow signals that promote the growth and spread of certain lung cancer cells. Treatment should be initiated by a specialist experienced in managing advanced non-small cell lung cancer. Regular monitoring may be required for liver function, diarrhea, skin reactions, eye problems, and respiratory symptoms. The recommended dose is 250 mg once daily and may be taken with or without food.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Film-Coated Tablet
Route of Administration Oral
Pack Size 30 Tablets
Manufacturer Natco Pharma Ltd

Product Also Known As

Gefinat 250 mg Tablet, Gefinat 250mg Tablet, Gefinat 250 Tablet, Gefitinib 250 mg Tablet, Gefitinib 250mg Tablet, Gefitinib Film-Coated Tablet, Gefitinib Anticancer Tablet